Antiprogestin and/or gonadotropin-releasing hormone agonist for endometriosis treatment and bone maintenance: a 1-year primate study

Condition tags

Citation neighborhood (2-hop)

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]

Cited by (12)

• Antiprogestins in gynecological diseases 2014
• [Interest of selective progesterone receptor modulators in endometriosis] 2013
• Progesterone Resistance and Targeting the Progesterone Receptors: A Therapeutic Approach to Endometriosis 2012
• The immninent dawn of SPRMs in obstetrics and gynecology 2012
• Tratamiento de la endometriosis con 5mg o 25mg diarios de mifepristona durante 6 meses. Ensayo clínico aleatorizado, doble ciego 2011
• The role of progestins in treating the pain of endometriosis 2006
• Hormonal regulation and localization of estrogen, progestin and androgen receptors in the endometrium of nonhuman primates: effects of progesterone receptor antagonists 2004
• Animal studies in endometriosis: a review 2004
• Progesterone antagonists and progesterone receptor modulators: an overview 2003
• Medical Therapy for Endometriosis 2003
• The role of selective oestrogen receptor modulators in the treatment of endometrial bleeding in women using long-acting progestin contraception 2000
• Modern medical management of endometriosis 1997

Source provenance

openalex

last seen: 2026-06-10T17:14:06.276822+00:00

unpaywall

last seen: 2026-10-13T06:25:51.201866+00:00